Literature DB >> 29953261

Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity.

Shaikh M Atif1, Sophie L Gibbings1, Elizabeth F Redente1, Faye A Camp2, Raul M Torres2, Ross M Kedl2, Peter M Henson1,2, Claudia V Jakubzick1,2.   

Abstract

Early recognition of neoantigen-expressing cells is complex, involving multiple immune cell types. In this study, in vivo, we examined how antigen-presenting cell subtypes coordinate and induce an immunological response against neoantigen-expressing cells, particularly in the absence of a pathogen-associated molecular pattern, which is normally required to license antigen-presenting cells to present foreign or self-antigens as immunogens. Using two reductionist models of neoantigen-expressing cells and two cancer models, we demonstrated that natural IgM is essential for the recognition and initiation of adaptive immunity against neoantigen-expressing cells. Natural IgM antibodies form a cellular immune complex with the neoantigen-expressing cells. This immune complex licenses surveying monocytes to present neoantigens as immunogens to CD4+ T cells. CD4+ T helper cells, in turn, use CD40L to license cross-presenting CD40+ Batf3+ dendritic cells to elicit a cytotoxic T cell response against neoantigen-expressing cells. Any break along this immunological chain reaction results in the escape of neoantigen-expressing cells. This study demonstrates the surprising, essential role of natural IgM as the initiator of a sequential signaling cascade involving multiple immune cell subtypes. This sequence is required to coordinate an adaptive immune response against neoantigen-expressing cells.

Entities:  

Keywords:  Ly6C+ monocytes; XCR1+ Batf3+ dendritic cells; cancer; natural IgM; neoantigens

Mesh:

Substances:

Year:  2018        PMID: 29953261      PMCID: PMC6236687          DOI: 10.1165/rcmb.2018-0159OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  74 in total

1.  Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism.

Authors:  Taeg S Kim; Stacey A Gorski; Steven Hahn; Kenneth M Murphy; Thomas J Braciale
Journal:  Immunity       Date:  2014-03-13       Impact factor: 31.745

2.  Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination.

Authors:  Wolfgang Kratky; Caetano Reis e Sousa; Annette Oxenius; Roman Spörri
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

3.  Binding of natural human IgM auto-antibodies to human tumor cell lines and stimulated normal T lymphocytes.

Authors:  J Bohn; D Roggenbuck; U Settmacher; W Döcke; H D Volk; R Von Baehr; S Jahn
Journal:  Immunol Lett       Date:  1994-02       Impact factor: 3.685

4.  Primary immune responses to H-Y in BALB/c-H-2k mice.

Authors:  R B Ashman
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Antibody production in mice. II. The mechanism of antigenic stimulation in the secondary immune response.

Authors:  T Hamaoka; M Kitagawa
Journal:  Immunology       Date:  1971-02       Impact factor: 7.397

Review 6.  Immunotherapy of cancer through targeting of minor histocompatibility antigens.

Authors:  Lothar Hambach; Els Goulmy
Journal:  Curr Opin Immunol       Date:  2005-04       Impact factor: 7.486

7.  The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.

Authors:  Krishanthi S Subramaniam; Kausik Datta; Eric Quintero; Catherine Manix; Matthew S Marks; Liise-Anne Pirofski
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

8.  Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness.

Authors:  Thomas A Ferguson; John Herndon; Bennett Elzey; Thomas S Griffith; Steve Schoenberger; Douglas R Green
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

9.  Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains.

Authors:  Lori D Dwyer-Nield; Jay McQuillan; Annie Hill-Baskin; Richard A Radcliffe; Ming You; Joseph H Nadeau; Alvin M Malkinson
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

10.  Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen.

Authors:  Jenette Creaney; Shaokang Ma; Sophie A Sneddon; Michelle R Tourigny; Ian M Dick; Justine S Leon; Andrea Khong; Scott A Fisher; Richard A Lake; W Joost Lesterhuis; Anna K Nowak; Shay Leary; Mark W Watson; Bruce W Robinson
Journal:  Oncoimmunology       Date:  2015-05-11       Impact factor: 8.110

View more
  11 in total

Review 1.  Agents of cancer immunosurveillance: HSPs and dsDNA.

Authors:  Devanshi A Nayak; Robert J Binder
Journal:  Trends Immunol       Date:  2022-04-02       Impact factor: 16.687

2.  Natural Antibodies Alert the Adaptive Immune System of the Presence of Transformed Cells in Early Tumorigenesis.

Authors:  Kavita Rawat; Shannon M Soucy; Fred W Kolling; Kiara Manohar Diaz; William T King; Anita Tewari; Claudia V Jakubzick
Journal:  J Immunol       Date:  2022-08-26       Impact factor: 5.426

3.  Advancing Lung Immunology Research: An Official American Thoracic Society Workshop Report.

Authors:  Rod A Rahimi; Josalyn L Cho; Claudia V Jakubzick; Shabaana A Khader; Bart N Lambrecht; Clare M Lloyd; Ari B Molofsky; Sebastien Talbot; Catherine A Bonham; Wonder P Drake; Anne I Sperling; Benjamin D Singer
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

4.  Claudia Jakubzick: Work hard, play hard.

Authors:  Stephanie Houston
Journal:  J Exp Med       Date:  2019-02-20       Impact factor: 17.579

Review 5.  Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review).

Authors:  Simona Ruxandra Volovat; Serban Negru; Cati Raluca Stolniceanu; Constantin Volovat; Cristian Lungulescu; Dragos Scripcariu; Bogdan Mihail Cobzeanu; Cipriana Stefanescu; Cristina Grigorescu; Iolanda Augustin; Corina Lupascu Ursulescu; Cristian Constantin Volovat
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

Review 6.  Engineering neoantigen vaccines to improve cancer personalized immunotherapy.

Authors:  Zaoqu Liu; Jinxiang Lv; Qin Dang; Long Liu; Siyuan Weng; Libo Wang; Zhaokai Zhou; Ying Kong; Huanyun Li; Yilin Han; Xinwei Han
Journal:  Int J Biol Sci       Date:  2022-09-01       Impact factor: 10.750

7.  Human and Mouse Transcriptome Profiling Identifies Cross-Species Homology in Pulmonary and Lymph Node Mononuclear Phagocytes.

Authors:  Sonia M Leach; Sophie L Gibbings; Anita D Tewari; Shaikh M Atif; Brian Vestal; Thomas Danhorn; William J Janssen; Tor D Wager; Claudia V Jakubzick
Journal:  Cell Rep       Date:  2020-11-03       Impact factor: 9.423

Review 8.  Duality of B Cell-CXCL13 Axis in Tumor Immunology.

Authors:  Angel J Rubio; Tyrone Porter; Xuemei Zhong
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

9.  Redefining innate natural antibodies as important contributors to anti-tumor immunity.

Authors:  Kavita Rawat; Anita Tewari; Madeline J Morrisson; Tor D Wager; Claudia V Jakubzick
Journal:  Elife       Date:  2021-10-05       Impact factor: 8.140

10.  LN Monocytes Limit DC-Poly I:C Induced Cytotoxic T Cell Response via IL-10 and Induction of Suppressor CD4 T Cells.

Authors:  Anita Tewari; Miglena G Prabagar; Sophie L Gibbings; Kavita Rawat; Claudia V Jakubzick
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.